Revolutionizing treatment for patients in need

Scroll To Discover
smiling Tarsus woman smiling Tarsus woman smiling Tarsus woman


We’re committed to delivering boundless therapeutic ingenuity

Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company that embodies the values of commitment, empowerment, and teamwork. We aim to bring novel therapeutics to patients across a range of diseases with limited treatment options.


Novel therapies, beginning with the eye

For the millions of patients living with Demodex blepharitis, an FDA-approved treatment is here.

News & Media

Here is the latest from Tarsus

11/09/2023 Tarsus Reports Third Quarter 2023 Financial Results and Recent Business Achievements
11/01/2023 Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
09/06/2023 Tarsus to Ring Nasdaq Stock Market Closing Bell in Celebration of the Launch of XDEMVY™, the First and Only FDA Approved Treatment for Demodex Blepharitis

Contact Tarsus

Please reach out to us using the form below.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.